Letaplimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Letaplimab Usage And Synthesis

Uses

Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis[1].

References

[1] Miao Miao, et al. A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome. MYELODYSPLASTIC SYNDROMES-CLINICAL AND EPIDEMIOLOGICAL NOVEMBER 15, 2022.

Letaplimab(2283356-07-8)Related Product Information

• Vepsitamab
• Simridarlimab
• Socazolimab
• Dafsolimab
• Ianalumab
• Emerfetamab
• Trinbelimab
• Ivicentamab
• Cergutuzumab Amunaleukin
• Ozoralizumab